Chen Guo-Ming相关文献与解析，生知库 | 链接生命科学的每一步

Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial

围手术期替雷利珠单抗联合化疗治疗局部晚期胃食管交界处腺癌（NEOSUMMIT-03）：一项前瞻性、非随机、开放标签的II期试验

期刊:Signal Transduction and Targeted Therapy

Nie, Run-Cong; Yuan, Shu-Qiang; Ding, Ya; Chen, Yong-Ming; Li, Yuan-Fang; Liang, Cheng-Cai; Cai, Mu-Yan; Chen, Guo-Ming; Wang, Wei; Sun, Xiao-Wei; Weng, De-Sheng; Li, Dan-Dan; Zhao, Jing-Jing; Chen, Xiao-Jiang; Guan, Yuan-Xiang; Liu, Zhi-Min; Liang, Yao; Luo, Ma; Chi, Jun; Qiu, Hai-Bo; Zhou, Zhi-Wei; Zhang, Xiao-Shi; Chen, Ying-Bo

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

围手术期双重 PD-1 和 HER2 阻断治疗 HER2 阳性胃癌的安全性和有效性

期刊:Cell Reports Medicine

影响因子:10.6

doi:10.1016/j.xcrm.2025.102190

Nie Run-Cong, Chen Xiao-Jiang, Liang Cheng-Cai, Zhao Bai-Wei, Wang Wei, Zhang Fei-Yang, Cai Mu-Yan, Qiu Hai-Bo, Xue Zhi-Cheng, Chen Guo-Ming, Liu Zhi-Min, Chi Jun, Duan Jin-Ling, Zhang Dong-Sheng, Chen Ying-Bo, Zhou Zhi-Wei, Chen Yong-Ming, Yuan Shu-Qiang, Li Yuan-Fang

Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.

长链非编码RNA在胃癌腹膜复发中的转录图谱和预测潜力

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-024-02196-4

Cai Xiao-Xia, Chen Guo-Ming, Zheng Zi-Qi, Yin Yi-Xin, Wang Shuang, Qiao Li, Chen Xiao-Jiang, Zhao Bai-Wei, Duan Jin-Ling, Liang Cheng-Cai, Zhang Ruo-Peng, Wei Cheng-Zhi, Zhang Fei-Yang, Huang Bo-Wen, Liu Ze-Xian, Zhou Zhi-Wei, Xie Dan, Cai Mu-Yan, Yuan Shu-Qiang, Li Yuan-Fang, Nie Run-Cong

Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer

mTOR/eIF4E 信号通路过度激活促进 EBV 阳性胃癌中色氨酸至苯丙氨酸取代物的产生

期刊:Advanced Science

影响因子:

doi:10.1002/advs.202402284

Zi-Qi Zheng, Cheng-Rui Zhong, Cheng-Zhi Wei, Xiao-Jiang Chen, Guo-Ming Chen, Run-Cong Nie, Ze-Wei Chen, Fei-Yang Zhang, Yuan-Fang Li, Zhi-Wei Zhou, Yong-Ming Chen, Ye-Lin Liang

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis

PD-L1表达在胃癌腹膜转移患者中的预后意义

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines11072003

Chen, Xiao-Jiang; Wei, Cheng-Zhi; Lin, Jun; Zhang, Ruo-Peng; Chen, Guo-Ming; Li, Yuan-Fang; Nie, Run-Cong; Chen, Yong-Ming

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis

晚期胃癌伴出口梗阻：姑息性胃切除术与胃空肠吻合术的倾向评分匹配分析

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-021-07904-7

Chen, Xiao-Jiang; Chen, Guo-Ming; Wei, Yi-Cheng; Yu, Hong; Wang, Xi-Cheng; Zhao, Zhou-Kai; Luo, Tian-Qi; Nie, Run-Cong; Zhou, Zhi-Wei

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis

抗PD-1/PD-L1单药治疗或联合治疗在75岁及以上患者中的疗效：一项研究层面的荟萃分析

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.538174

Nie, Run-Cong; Chen, Guo-Ming; Wang, Yun; Zhou, Jie; Duan, Jin-Ling; Zhou, Zhi-Wei; Yuan, Shu-Qiang

Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data

体重指数与接受免疫检查点抑制剂治疗患者的生存结局之间的关联：个体患者数据的荟萃分析

期刊:Journal of Immunotherapy

影响因子:2.9

doi:10.1097/CJI.0000000000000389

Nie, Run-Cong; Chen, Guo-Ming; Wang, Yun; Yuan, Shu-Qiang; Zhou, Jie; Duan, Jin-Ling; Liu, Wen-Wu; Chen, Shi; Cai, Mu-Yan; Li, Yuan-Fang

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma

晚期黑色素瘤抗程序性死亡受体-1和抗程序性死亡配体-1试验中总生存期的替代终点

期刊:Therapeutic Advances in Medical Oncology

影响因子:4.2

doi:10.1177/1758835920929583

Nie, Run-Cong; Yuan, Shu-Qiang; Wang, Yun; Zou, Xue-Bin; Chen, Shi; Li, Shu-Man; Duan, Jin-Ling; Zhou, Jie; Chen, Guo-Ming; Luo, Tian-Qi; Zhou, Zhi-Wei; Li, Yuan-Fang

Cellular senescence in gastric cancer: a novel prognostic stratification and immune predictor

胃癌中的细胞衰老：一种新的预后分层和免疫预测因子

Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial

围手术期替雷利珠单抗联合化疗治疗局部晚期胃食管交界处腺癌（NEOSUMMIT-03）：一项前瞻性、非随机、开放标签的II期试验

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

围手术期双重 PD-1 和 HER2 阻断治疗 HER2 阳性胃癌的安全性和有效性

Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.

长链非编码RNA在胃癌腹膜复发中的转录图谱和预测潜力

Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer

mTOR/eIF4E 信号通路过度激活促进 EBV 阳性胃癌中色氨酸至苯丙氨酸取代物的产生

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis

PD-L1表达在胃癌腹膜转移患者中的预后意义

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis

晚期胃癌伴出口梗阻：姑息性胃切除术与胃空肠吻合术的倾向评分匹配分析

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis

抗PD-1/PD-L1单药治疗或联合治疗在75岁及以上患者中的疗效：一项研究层面的荟萃分析

Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data

体重指数与接受免疫检查点抑制剂治疗患者的生存结局之间的关联：个体患者数据的荟萃分析

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma

晚期黑色素瘤抗程序性死亡受体-1和抗程序性死亡配体-1试验中总生存期的替代终点